AF
OPRX icon

Amalgamated Financial’s OptimizeRx OPRX Stock Holding History

Amalgamated Financial’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$323K Buy
+8,569
New +$379K ﹤0.01% 1705

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Amalgamated Financial's OPRX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in OptimizeRx (OPRX) in Q1 2022: 8,569 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #1705 among its holdings.

153 funds tracked by Wall St. Rank hold OPRX as of Q1 2022.

  • Amalgamated Financial held 8,569 shares of OptimizeRx worth $323K as of Q1 2022.
  • OptimizeRx was a new Amalgamated Financial position in Q1 2022.
  • OptimizeRx made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1705 holding.
  • 153 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.